Diets
mediterranean diet promotes-reversion-of metabolic syndrome
In plain terms: Does a Mediterranean diet help reverse metabolic syndrome (waist, glucose, lipids, blood pressure)?
Part of: 🥗 mediterranean diet
Yes — PREDIMED RCT data and RCT meta-analyses show the Mediterranean diet improves all metabolic-syndrome components and promotes its reversion, though usually as part of broader lifestyle change.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Montemayor 2022 · Nutrients | observational | supports | low | FLIPAN randomized lifestyle trial with a customized MedDiet reduced NAFLD and improved metabolic-syndrome features in MetS patients. |
| Reinoso-Barbero L et al 2026 · study_type: observational | observational | supports | low | Cross-sectional, n=5891 workers: MD adherence inversely assoc. w/ MetS prevalence, OR 0.45 (95% CI 0.31-0.68); components: HDL 0.63, TG 0.57, waist 0.62, glucose 0.67; BP ns 0.85 (0.70-1.04) |
| Calzada 2026 · Clin Nutr ESPEN | RCT | supports | moderate | Randomized MedDiet intervention in a non-Mediterranean (Chilean) population showed early reversal of metabolic-syndrome parameters at 6 months. |
| Galbete 2018 · Eur J Epidemiol | observational | tested-null | low | Off-scope for metabolic syndrome. The umbrella's inclusion criteria enumerate the endpoints exhaustively — '(4) study endpoints include overall cancer mortality and/or incidence, CVD or coronary heart disease (CHD) mortality and/or incidence, stroke, myocardial infarction (MI), acute myocardial infarction (AMI) type 2 diabetes, Alzheimer's disease (AD), mild cognitive impairment (MCI), or dementia' — metabolic syndrome is not among them, and the phrases 'metabolic syndrome', 'waist circumference', 'triglyceride', 'HDL' and 'blood pressure' appear nowhere in the full text including references. It is also an umbrella of incidence meta-analyses in prospective cohorts, which cannot speak to reversion of an already-present condition. |
| Chatzi 2024 · Nutrients | meta-analysis | supports | moderate | Umbrella review of systematic reviews found the Mediterranean dietary pattern favorably affects cardiometabolic risk factors in people with existing risk factors. |
| Ruiz-Canela 2025 · Ann Intern Med | RCT | supports | high | PREDIMED-Plus, n=4746, all with metabolic syndrome AT BASELINE (entry criterion). The paper's stated outcomes are 'Diabetes incidence was based on the American Diabetes Association criteria. Anthropometric measurements were obtained annually.' - metabolic-syndrome reversion or remission is never reported. The only MetS-adjacent result is directional and unquantified in the abstract: 'The intervention group attained better adherence to the erMedDiet, higher physical activity levels, and greater reductions in body weight and waist circumference.' The prior extract's 'improved cardiometabolic risk' is not a finding the paper states. Off-scope: wrong outcome, and both arms received a Mediterranean diet. |
| Haro 2017 · Mol Nutr Food Res | RCT | mixed | low | CORDIOPREV substudy showed both Mediterranean and low-fat diets partially restored gut microbiota in metabolically dysfunctional obese patients, with effect depending on baseline dysfunction. |
| Eichelmann 2024 · Nat Med | observational | tested-null | low | Off-scope for metabolic-syndrome reversion. The paper's endpoints are lipidome change and incident disease counts only — 'Importantly, these analyses are restricted to T2D risk.' — and its PREDIMED analysis reports T2D incidence by baseline lipidomic stratum (42%, 95% CI: 15% to 61% reduction below median rMLS; 3%, 95% CI: 36%-decrease to 48%-increase above it), never MetS status, MetS components as a syndrome definition, or remission. The term 'metabolic syndrome' does not occur in the article. |
| Papadaki 2020 · Nutrients | meta-analysis | mixed | high | Meta-analysis of controlled trials found the Mediterranean diet reduced metabolic-syndrome incidence and improved waist circumference, glucose, HDL, triglycerides, and blood pressure. |
| Klein 2026 · Circulation | RCT | supports | high | 5- and 10-year follow-up of CENTRAL and DIRECT-PLUS RCTs linked (green-)Mediterranean-diet-induced visceral fat loss to durable improvement in cardiometabolic profile. |
| Salas-Salvado 2015 · J Nutr | RCT | supports | high | Review anchored on PREDIMED RCT: MedDiet promoted reversion of metabolic syndrome (notably hyperglycemia and central obesity); RCT meta-analysis showed benefit on all MetS components. |
| Zhou L et al 2026 · study_type: observational | observational | supports | moderate | Retrospective, n=1300 older adults w/ MetS; MedDiet-style + multi-component nutrition care; 41.4% partial/total MetS resolution; component deltas (glucose -7.9mg/dL, TG -24.9, HDL/LDL, waist -3.8cm, SBP -7.7mmHg) |
| Hernandez 2025 · J Am Nutr Assoc | meta-analysis | supports | high | Meta-analysis of 26 RCTs in overweight/obese adults found MedDiet improved multiple cardiovascular risk factors including anthropometry, lipids, blood pressure, and glucose. |
| Chan 2025 · Eur J Prev Cardiol | meta-analysis | mixed | high | Network meta-analysis: multimodal (diet + exercise) interventions outperform nutrition-alone for MetS reversal — MedDiet effective but strongest when combined. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.